| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,372,000 | 1,500,000 | 1,350,000 | 1,216,000 | | Cost of Revenue | 753,000 | 813,000 | 739,000 | 730,000 | | | Gross Profit | 619,000 | 687,000 | 611,000 | 486,000 | | | Operating Expenses | | Research Development | 27,000 | 33,000 | 27,000 | 27,000 | | Selling General and Administrative | 302,000 | 333,000 | 299,000 | 279,000 | | Non Recurring | 2,000 | 4,000 | 14,000 | 1,000 | | Others |
-
| 7,000 |
-
|
-
| | | | Total Operating Expenses |
-
| 377,000 |
-
|
-
| | | | Operating Income or Loss | 288,000 | 310,000 | 271,000 | 179,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (8,000) | (21,000) | 1,000 | (4,000) | | Earnings Before Interest And Taxes | 280,000 | 297,000 | 272,000 | 175,000 | | Interest Expense | 36,000 | 36,000 | 39,000 | 44,000 | | Income Before Tax | 244,000 | 261,000 | 233,000 | 131,000 | | Income Tax Expense | 87,000 | 91,000 | 80,000 | 45,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 157,000 | 170,000 | 153,000 | 86,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 157,000 | 170,000 | 153,000 | 86,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $157,000 | $170,000 | $153,000 | $86,000 |
|
0.31% Nasdaq 
0.05%
Income Statement
